Evergreen Hematology and Oncology

Spokane, Washington 99218

0 studies enrolling now · 8 studies all time

What they study most

Breast Cancer, Estrogen Receptor Positive Tumor, HER-2 Gene Amplification, Hematologic Malignancies, Hepatic Impairment, Metastatic Breast Cancer, Non-Small Cell Lung Cancer, Prostate Cancer, Solid Tumors, Stage IV Pancreatic Cancer

Studies at this site

• Pilot Study Using Molecular Profiling to Find Potential Targets & Select Treatments for Pts With Met br ca — Completed
• Eribulin in Combination With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive Early Stage Breast Cancer — Completed
• A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer — Stopped early
• Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer — Completed
• Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic Impairment — Completed
• Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer — Completed
• Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer — Completed
• A Study of MM-111 in Combination With Multiple Treatments in Patients With HER2 Positive Cancer — Completed